The purpose of his research is to determine the benefits of using stimulant medications for treating young children with ADD/ADHD. The study has been reviewed and approved by WSU's Institutional Research Board for Human Subjects, which works to protect research participants by maximizing anticipated benefits and minimizing possible risks of harm.